THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

Go back to THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
(NASDAQ: TBPH) Delayed: 17.02 -0.02 (0.12%)
Previous Close $17.04    52 Week High $38.92 
Open $17.03    52 Week Low $12.87 
Day High $17.05    P/E N/A 
Day Low $17.02    EPS $0.00 
Volume 683,741